The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Glutamate Receptor Ionotropic NMDA 2B Market Research Report 2024
Synopsis
The global Glutamate Receptor Ionotropic NMDA 2B market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Glutamate Receptor Ionotropic NMDA 2B is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Glutamate Receptor Ionotropic NMDA 2B is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Glutamate Receptor Ionotropic NMDA 2B include BioCrea GmbH, Bristol-Myers Squibb Company, Cerecor Inc., Johnson & Johnson, Luc Therapeutics, Inc., NeurOp, Inc, Novartis AG and UCB S.A., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Glutamate Receptor Ionotropic NMDA 2B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glutamate Receptor Ionotropic NMDA 2B.
Report Scope
The Glutamate Receptor Ionotropic NMDA 2B market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glutamate Receptor Ionotropic NMDA 2B market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glutamate Receptor Ionotropic NMDA 2B manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioCrea GmbH
Bristol-Myers Squibb Company
Cerecor Inc.
Johnson & Johnson
Luc Therapeutics, Inc.
NeurOp, Inc
Novartis AG
UCB S.A.
Segment by Type
JNJ-0808
Neu-2000
NP-10679
NP-11948
Radiprodil
Others
Segment by Application
Acute Ischemic Stroke
Autism
Brain Ischemia
Burns
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glutamate Receptor Ionotropic NMDA 2B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glutamate Receptor Ionotropic NMDA 2B in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Glutamate Receptor Ionotropic NMDA 2B market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Glutamate Receptor Ionotropic NMDA 2B is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Glutamate Receptor Ionotropic NMDA 2B is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Glutamate Receptor Ionotropic NMDA 2B include BioCrea GmbH, Bristol-Myers Squibb Company, Cerecor Inc., Johnson & Johnson, Luc Therapeutics, Inc., NeurOp, Inc, Novartis AG and UCB S.A., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Glutamate Receptor Ionotropic NMDA 2B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glutamate Receptor Ionotropic NMDA 2B.
Report Scope
The Glutamate Receptor Ionotropic NMDA 2B market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glutamate Receptor Ionotropic NMDA 2B market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glutamate Receptor Ionotropic NMDA 2B manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioCrea GmbH
Bristol-Myers Squibb Company
Cerecor Inc.
Johnson & Johnson
Luc Therapeutics, Inc.
NeurOp, Inc
Novartis AG
UCB S.A.
Segment by Type
JNJ-0808
Neu-2000
NP-10679
NP-11948
Radiprodil
Others
Segment by Application
Acute Ischemic Stroke
Autism
Brain Ischemia
Burns
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glutamate Receptor Ionotropic NMDA 2B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glutamate Receptor Ionotropic NMDA 2B in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Glutamate Receptor Ionotropic NMDA 2B Market Overview
1.1 Product Overview and Scope of Glutamate Receptor Ionotropic NMDA 2B
1.2 Glutamate Receptor Ionotropic NMDA 2B Segment by Type
1.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Value Comparison by Type (2024-2030)
1.2.2 JNJ-0808
1.2.3 Neu-2000
1.2.4 NP-10679
1.2.5 NP-11948
1.2.6 Radiprodil
1.2.7 Others
1.3 Glutamate Receptor Ionotropic NMDA 2B Segment by Application
1.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Value by Application: (2024-2030)
1.3.2 Acute Ischemic Stroke
1.3.3 Autism
1.3.4 Brain Ischemia
1.3.5 Burns
1.3.6 Others
1.4 Global Glutamate Receptor Ionotropic NMDA 2B Market Size Estimates and Forecasts
1.4.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue 2019-2030
1.4.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales 2019-2030
1.4.3 Global Glutamate Receptor Ionotropic NMDA 2B Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Glutamate Receptor Ionotropic NMDA 2B Market Competition by Manufacturers
2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Manufacturers (2019-2024)
2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Glutamate Receptor Ionotropic NMDA 2B Average Price by Manufacturers (2019-2024)
2.4 Global Glutamate Receptor Ionotropic NMDA 2B Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B, Product Type & Application
2.7 Glutamate Receptor Ionotropic NMDA 2B Market Competitive Situation and Trends
2.7.1 Glutamate Receptor Ionotropic NMDA 2B Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glutamate Receptor Ionotropic NMDA 2B Players Market Share by Revenue
2.7.3 Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glutamate Receptor Ionotropic NMDA 2B Retrospective Market Scenario by Region
3.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Glutamate Receptor Ionotropic NMDA 2B Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region: 2019-2030
3.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region: 2019-2024
3.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region: 2025-2030
3.3 Global Glutamate Receptor Ionotropic NMDA 2B Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region: 2019-2030
3.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region: 2019-2024
3.3.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region: 2025-2030
3.4 North America Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country
3.4.1 North America Glutamate Receptor Ionotropic NMDA 2B Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2019-2030)
3.4.3 North America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country
3.5.1 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2019-2030)
3.5.3 Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country
3.6.1 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2019-2030)
3.6.3 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country
3.7.1 Latin America Glutamate Receptor Ionotropic NMDA 2B Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2019-2030)
3.7.3 Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country
3.8.1 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2019-2030)
3.8.3 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2019-2030)
4.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2019-2024)
4.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2025-2030)
4.1.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2019-2030)
4.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2019-2030)
4.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2019-2024)
4.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2025-2030)
4.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2019-2030)
4.3 Global Glutamate Receptor Ionotropic NMDA 2B Price by Type (2019-2030)
5 Segment by Application
5.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2019-2030)
5.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2019-2024)
5.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2025-2030)
5.1.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2019-2030)
5.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2019-2030)
5.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2019-2024)
5.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2025-2030)
5.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2019-2030)
5.3 Global Glutamate Receptor Ionotropic NMDA 2B Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BioCrea GmbH
6.1.1 BioCrea GmbH Corporation Information
6.1.2 BioCrea GmbH Description and Business Overview
6.1.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.1.5 BioCrea GmbH Recent Developments/Updates
6.2 Bristol-Myers Squibb Company
6.2.1 Bristol-Myers Squibb Company Corporation Information
6.2.2 Bristol-Myers Squibb Company Description and Business Overview
6.2.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.2.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.3 Cerecor Inc.
6.3.1 Cerecor Inc. Corporation Information
6.3.2 Cerecor Inc. Description and Business Overview
6.3.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.3.5 Cerecor Inc. Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Luc Therapeutics, Inc.
6.5.1 Luc Therapeutics, Inc. Corporation Information
6.5.2 Luc Therapeutics, Inc. Description and Business Overview
6.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.5.5 Luc Therapeutics, Inc. Recent Developments/Updates
6.6 NeurOp, Inc
6.6.1 NeurOp, Inc Corporation Information
6.6.2 NeurOp, Inc Description and Business Overview
6.6.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2019-2024)
6.6.4 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.6.5 NeurOp, Inc Recent Developments/Updates
6.7 Novartis AG
6.6.1 Novartis AG Corporation Information
6.6.2 Novartis AG Description and Business Overview
6.6.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.7.5 Novartis AG Recent Developments/Updates
6.8 UCB S.A.
6.8.1 UCB S.A. Corporation Information
6.8.2 UCB S.A. Description and Business Overview
6.8.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2019-2024)
6.8.4 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.8.5 UCB S.A. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glutamate Receptor Ionotropic NMDA 2B Industry Chain Analysis
7.2 Glutamate Receptor Ionotropic NMDA 2B Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glutamate Receptor Ionotropic NMDA 2B Production Mode & Process
7.4 Glutamate Receptor Ionotropic NMDA 2B Sales and Marketing
7.4.1 Glutamate Receptor Ionotropic NMDA 2B Sales Channels
7.4.2 Glutamate Receptor Ionotropic NMDA 2B Distributors
7.5 Glutamate Receptor Ionotropic NMDA 2B Customers
8 Glutamate Receptor Ionotropic NMDA 2B Market Dynamics
8.1 Glutamate Receptor Ionotropic NMDA 2B Industry Trends
8.2 Glutamate Receptor Ionotropic NMDA 2B Market Drivers
8.3 Glutamate Receptor Ionotropic NMDA 2B Market Challenges
8.4 Glutamate Receptor Ionotropic NMDA 2B Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
